Furthermore, we observed a significant increase in DUSP6 expression in epithelial cells throughout tumor progression, and once again, a notable decrease in DUSP6 expression in PDAC primary tumors, followed by upregulation in metastatic samples (Fig. 2E). This evidence concerns the gene DUSP6 and neoplasm.